Digital Pathology Market – Trends Forecast Till 2030

Market Snapshot

Market Overview

The global Digital Pathology Market size is 799.296 million USD in 2022 and is projected to reach a CAGR of 8.6% from 2023-2030.

Digital pathology is a computer-enabled, image-based information platform that helps the management of information generated from digital slides. Digital pathology technology can aid a research pipeline in two ways. The first one is that the specified file storage and viewing applications may be used to arrange macroscopic images, tissue microarrays, and entire slide images. The second application of digital pathology in research is the development and implementation of image analysis techniques.

Growth of the global digital pathology market is majorly driven by the increase in the prevalence of cancer; a rise in the demand for accurate diagnostics, and the development of new digital pathology systems by a large number of key players. According to a report published by Medscape, chronic diseases can be associated with a higher mortality rate. The fundamental cause for the development of advanced diagnostic solutions is the rise prevalence of cardiovascular disorders. Thus, as the prevalence of chronic and cardiovascular diseases rises, the need for digital pathology systems increases driving the growth of the digital pathology market. Also, the Rise in the geriatric population and rapid technological advancements in digital pathology systems are the factors that fuel the growth of the digital pathology market.

On the other hand, the high cost of A typical digital pathology system, coupled with the lack of skilled personnel to operate them is expected to limit the adoption of these systems.  The cost, which includes a slide scanner, an image server, and software, costs around USD 500,000 to USD 700,000.  While in the Asia Pacific, the average price is around USD 110,000 to USD 130,000. Although large hospitals with significant capital budgets can afford these systems, pathologists and academic institutes with limited budgets or IT support often cannot afford them, this significantly restricts the Digital Pathology Market

The COVID-19 outbreak is anticipated to have a positive impact to fuel the growth of the global digital pathology market. Thus, the rise in cases of chronic diseases has increased the usage of digital pathology systems for diagnosis, which is anticipated to drive the digital pathology market during the forecast period.

Delvens Industry Expert's Standpoint

Due to its ability to ascertain and comprehend the causes of diseases, digital diagnosis plays a significant role in the diagnosis of many chronic diseases. The efficiency, effectiveness, and safety of disease diagnosis in pathology laboratories are improved by the integration of digital pathology with digital tools like barcoding, specimen tracking, digital dictation, and others. Multiple pathologists can instantly share entire slides through a digital pathology platform to contribute to a case at once. The rise in the incidence of cancer, the requirement for precise diagnoses, and the creation of innovative digital pathology systems are the primary factors driving the worldwide market for digital pathology.

Market Portfolio

Key Findings

• The scanners segment is further segmented into Scanners, Software, and Storage systems. The scanners segment is expected to hold the highest orientation during the forecast period. The large share of the scanners segment can be attributed to the high price of scanners and the increasing adoption of digital pathology solutions.

• The type segment is further segmented into Human Pathology and Veterinary Pathology. The human pathology segment is anticipated to hold the largest share during the forecast period. This is due to the increasing number of cancer research activities and growing collaborations among research institutes, universities, and pathology laboratories.

• The application segment is further fragmented into Drug Discovery, Disease Diagnosis, and Training & Education. The drug discovery segment is expected to reach the highest CAGR during the forecast period. Growth in R&D expenditure fuelled by the need for numerous preclinical and clinical studies performed during the drug discovery and development process is a major factor responsible for market growth.

• The end-user segment is further segmented into Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, and Academic & Research Institutes. The segment is expected to hold the largest share in Pharmaceutical & Biotechnology Companies. The large share of this segment can be attributed to the increasing use of digital pathology for drug discovery studies and drug toxicology testing. Biotechnology companies also use digital pathology for biobanking, biopharmaceutical studies, molecular assays, and the development of individualized medicine.
   

Regional Analysis

North America to Dominate the Market

• North America accounted for the largest share of the digital pathology market during the forecast period. The increasing prevalence of cancer, rising demand for quality diagnostics, the introduction of favorable reimbursement policies, and the implementation of favorable initiatives by the governments in the US and Canada are major factors driving the growth of the digital pathology market in North America.

Competitive Landscape

• 3DHistech Ltd
• Danaher Corporation
• Glencoe Software Inc.
• HAMAMATSU Photonics K.K
• Indica Labs Inc.
• Koninklijke Philips N.V
• Nikon Corporation
• Perkinelmer Inc.
• Roche
• VisoPharma A/S.

Recent Developments

• In September 2021, Visiopharm (Denmark) and Agilent Technologies, Inc. (US) collaborated to co-market Visiopharm’s portfolio of CE-IVD marked AI-driven Precision Pathology software and Agilent’s automated pathology staining solutions portfolio.
   
• In August 2021, Sectra AB (Sweden) and University Medical Center Utrecht (Netherlands) signed an agreement under which UMC uses Sectra’s pathology module for effective multidisciplinary discussions among pathologists and radiologists.

Reasons to Acquire

• Increase your understanding of the market for identifying the best and most suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
   
• Gain authentic and granular data access for Digital Pathology Market so as to understand the trends and the factors involved in changing market situations
   
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
   
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope